Beasley, Allen, Crow, Methvin, Portis & Miles, P.C.

SAN FRANCISCO (Thomson Financial) – Alfacell Corp. late Wednesday said results from its Phase IIIB clinical trial for Onconase, which was being studied as a potential treatment for unresectable malignant mesothelioma, didn’t meet the trial’s primary endpoint.

Read the rest of this entry »

A report published by the Insurance Journal on May 28 says a group of Spanish workers injured by asbestos-containing insulation while working on Navy ships docked in Spain can sue the manufacturer of the insulation in New Jersey — where the products were produced.

Read the rest of this entry »